share_log

博腾股份(300363.SZ):拟参与认购投资基金份额

Boteng Co., Ltd. (300363.SZ): Intended to participate in the subscription of investment fund shares

Gelonghui Finance ·  Feb 23 04:56

Gelonghui, Feb. 23 | Boteng Co., Ltd. (300363.SZ) announced that the company plans to invest no more than 50 million yuan with its own funds to participate in the Suzhou Xingze Xingyong Emerging Medical Industry Investment Fund Management Partnership managed by Shanghai Xingze Investment Management Co., Ltd., as a limited partner, with a fund size of 15-20 billion yuan. It mainly invests in innovative biomedicine, biotherapy, and bioengineering products, including and not limited to macromolecular biopharmaceuticals, small-molecule targeted drugs, cell therapy, gene therapy, etc.; innovative medical devices, including and not limited to innovative consumables and devices; and R&D contract outsourcing (CRO), circulating tumor testing and other related fields in the industry chain.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment